Liu Xiao-Jun, Wan Zhao-Fei, Zhao Na, Zhang Ya-Ping, Mi Lan, Wang Xin-Hong, Zhou Dong, Wu Yan, Yuan Zu-Yi
Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
First Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Cardiovasc Diabetol. 2015 Aug 19;14:110. doi: 10.1186/s12933-015-0274-4.
The Global Registry of Acute Coronary Events (GRACE) risk score is widely recommended for risk assessment in patients with acute coronary syndrome (ACS). Chronic hyperglycemia [hemoglobinA1c (HbA1c)] can independently predict major adverse cardiac events (MACEs) in patients with ACS. We investigated whether the prediction of MACEs with the GRACE score could be improved with the addition of HbA1c content in ACS patients without diabetes mellitus (DM) undergoing percutaneous coronary intervention (PCI).
We enrolled 549 ACS patients without DM who underwent PCI. The GRACE score and HbA1c content were determined on admission. Correlation was analyzed by Spearman's rank correlation. Cumulative MACE curve was calculated using the Kaplan-Meier method. Multivariate Cox regression was used to identify predictors of MACEs. Additionally, the predictive value of HbA1c content alone and combined with GRACE score was estimated by the area under the receiver-operating characteristic curve (AUC), continuous net reclassification improvement (NRI) and integrated discrimination improvement (IDI).
During a median of 42.3 months (interquartile range 39.3-44.2 months), 16 (2.9%) were lost to follow-up, and patients experienced 69 (12.9%) MACEs: 51 (9.6%) all-cause deaths and 18 (3.4%) nonfatal myocardial infarction cases. The GRACE score was positively associated with HbA1c content. Multivariate Cox analysis showed that both GRACE score and HbA1c content were independent predictors of MACEs (hazard ratio 1.030; 95% CI 1.020-1.040; p < 0.001; 3.530; 95% CI 1.927-6.466; p < 0.001, respectively). Furthermore, Kaplan-Meier analysis demonstrated increased risk of MACEs with increasing HbA1c content (log-rank 33.906, p < 0.001). Adjustment of the GRACE risk estimate by HbA1c improved the predictive value of the GRACE score [increase in AUC from 0.75 for the GRACE score to 0.80 for the GRACE score plus HbA1c, p = 0.012; IDI = 0.055, p < 0.001; NRI (>0) = 0.70, p < 0.001].
HbA1c content is positively associated with GRACE risk score and their combination further improved the risk stratification for ACS patients without DM undergoing PCI.
全球急性冠状动脉事件注册研究(GRACE)风险评分被广泛推荐用于急性冠状动脉综合征(ACS)患者的风险评估。慢性高血糖[糖化血红蛋白(HbA1c)]可独立预测ACS患者的主要不良心脏事件(MACE)。我们研究了在接受经皮冠状动脉介入治疗(PCI)的非糖尿病(DM)ACS患者中,加入HbA1c含量是否能改善GRACE评分对MACE的预测。
我们纳入了549例接受PCI的非DM ACS患者。入院时测定GRACE评分和HbA1c含量。采用Spearman等级相关分析相关性。使用Kaplan-Meier方法计算累积MACE曲线。采用多变量Cox回归确定MACE的预测因素。此外,通过受试者工作特征曲线下面积(AUC)、连续净重新分类改善(NRI)和综合辨别改善(IDI)评估单独的HbA1c含量以及与GRACE评分联合使用时的预测价值。
在中位42.3个月(四分位间距39.3 - 44.2个月)的随访期间,16例(2.9%)失访,患者发生69例(12.9%)MACE:51例(9.6%)全因死亡和18例(3.4%)非致命性心肌梗死病例。GRACE评分与HbA1c含量呈正相关。多变量Cox分析显示,GRACE评分和HbA1c含量均为MACE的独立预测因素(风险比分别为1.030;95%CI 1.020 - 1.040;p < 0.001;3.530;95%CI 1.927 - 6.466;p < 0.001)。此外,Kaplan-Meier分析表明,随着HbA1c含量增加,MACE风险增加(对数秩检验33.906,p < 0.001)。用HbA1c调整GRACE风险估计值可提高GRACE评分的预测价值[GRACE评分的AUC从0.75增加到GRACE评分加HbA1c时的0.80,p = 0.012;IDI = 0.055,p < 0.001;NRI(>0)= 0.70,p < 0.001]。
HbA1c含量与GRACE风险评分呈正相关,二者联合可进一步改善接受PCI的非DM ACS患者的风险分层。